瑞康医药：董事、董秘及副总裁李喆被采取留置措施

Core Viewpoint - The company announced that its director, board secretary, and vice president Li Zhe has been subjected to detention measures by the Jinan Municipal Jiyang District Supervisory Committee, but this will not significantly impact the company's normal operations [1] Group 1 - Li Zhe is currently under detention, and during this period, the company's securities affairs representative Wang Xiuting will act as the board secretary [1] - The company maintains a sound governance structure and internal control mechanisms, with all other directors, supervisors, and senior management continuing to perform their duties normally [1] - The production and operational order of the company and its subsidiaries remain normal, indicating stability in business activities despite the situation [1]